Let’s make it happen
LentiVector advertising campaign
With Oxford BioMedica’s science now a reality with the successful approval of the Novartis Kymriah CART-T cell therapy for blood cancer and young adults, thinkerdoer developed an advertising campaign highlighting how their LentiVector platform can help others bring their new drugs to market.
The campaign is being adapted for use in trade press, online, exhibitions and conferences such as the 2017 European Society of Gene and Cell Therapy (ESGCT) XXV Anniversary Congress in Berlin where the campaign was rolled out for the first time, and the prestigious Cell and Gene Meeting on the Mesa in La Jolla, San Diego.
marketing collateral / advertising / conference and exhibition materials